News and Trends 7 Aug 2018
First 3D Placenta Model Helps Study Pregnancy Disorders
Austrian researchers have created a miniature 3D model of the human placenta, which could help us understand the causes of…
Alexander Burik
About
Born in Chicago, I grew up close to Frankfurt, Germany. I hold an MSc in Neuroscience from University College London and a BA in Biochemistry from Knox College in the US.
Outside of science-related activities, I enjoy skiing and writing music.
Articles by Alexander Burik
News and Trends 7 Aug 2018
Update: Seaweed-Derived Treatment for Common Cold Approved in the EU
Update (07/08/2018): Marinomed Biotech has obtained EU approval to sell a nasal spray containing a polymer derived from red seaweed…
News and Trends 6 Aug 2018
New Gene Therapy Could Treat Cystic Fibrosis With One Dose
A new partnership in the UK will develop a gene therapy for cystic fibrosis that could treat the disease with…
News and Trends 3 Aug 2018
Precision Antibiotic Improves Outcome of Gut Infections in Phase II
Summit Therapeutics obtained Phase II results showing its antibiotic for C. difficile infections was more effective in reducing the recurrence…
ADVERTISEMENT
Startup Scout 3 Aug 2018
This Biotech Targets the Neuronal Causes of Hearing Loss
Today, we’re in Archamps, France, visiting Pragma Therapeutics, a neuroscience biotech developing drugs to regulate neuronal signalling in hearing loss.…
More News! 2 Aug 2018
Tomato DNA Could Help Uncover Counterfeit Breast Implants
Counterfeit breast implants can harm patients’ health and even threaten their lives. A German research team is using tomato DNA…
News and Trends 2 Aug 2018
EMA Temporarily Scales Back Activities to Prepare for Brexit
As a result of Brexit, the European Medicines Agency will suspend some of its activities to prepare for staff cuts…
News and Trends 31 Jul 2018
Recycled Forestry Waste Could Make Cosmetics, Plastics and Biofuel
An EU project is using forestry waste to make 2,3-butanediol, a chemical with a wide range of industrial applications, from…
News and Trends 31 Jul 2018
Israeli Crohn’s Disease Drug Rakes in Positive Phase III Results
RedHill Biopharma has obtained positive Phase III results for its Crohn’s disease treatment, which targets a certain type of gut…
More News! 30 Jul 2018
We May Soon Diagnose Traumatic Brain Injury With a Single Drop of Blood
Swiss and Spanish researchers are developing a diagnostic test that measures the severity of mild traumatic brain injury that delivers…
News and Trends 26 Jul 2018
Replimune’s €85M IPO set to Boost Oncolytic Immunotherapy Pipeline
The US-UK biotech completed its $100M (€85M) IPO on the NASDAQ stock exchange to further develop 'oncolytic' immunotherapies that use the…
News and Trends 25 Jul 2018
Austrian Researchers Grow Cancerous Mini Brains in a Dish
Researchers in Vienna are growing mini brains that mimic the onset and development of brain cancer, which could be used…
News and Trends 24 Jul 2018
Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic
Celyad has received FDA approval to start clinical trials for its CAR-T cell therapy, which is engineered to avoid side…
News and Trends 23 Jul 2018
UK Biotech to Launch Rapid, Accurate HIV Test in Europe
UK-biotech Owen Mumford plans to launch an HIV diagnostic test in Europe that can produce an accurate result within 15…
News and Trends 23 Jul 2018
Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease
Sangamo Therapeutics has acquired TxCell with a view to utilizing its CAR-T technology to prevent organ transplant rejections and treat…
News and Trends 20 Jul 2018
German Private Equity Firm Raises €90M for Life Sciences and Medtech
SHS has raised €90M in the first closing of its fifth fund dedicated to companies in life sciences and medtech.…
ADVERTISEMENT
News and Trends 17 Jul 2018
Gene Therapy Could Prevent Deadly Brain Disease
An international research team used gene therapy to prevent Gaucher disease, a potentially deadly neurodegenerative condition, in mice. The approach…
News and Trends 16 Jul 2018
Series A Boost for Swedish Biotech’s Sickle Cell Disease Treatment
Modus Therapeutics closed SEK 140M (€13.5M) in Series A financing to complete a Phase II study testing its sickle cell…
News and Trends 13 Jul 2018
French Biotech Raises €12.5M for Antibiotic Booster Drugs
French-biotech Antabio closed €12.5M at series A to fund its pipeline of antibiotic booster drugs that should help in the…
News and Trends 12 Jul 2018
Collaboration Worth Over €1Bn Could Give Rise to New Cancer Immunotherapies
Genmab is partnering with the German company Immatics to develop immunotherapies directed against three cancer targets. Genmab has offered Immatics,…